Approximately one to two people per million worldwide are diagnosed with the ultra-rare kidney disease every year ...
The European Medicines Agency’s (EMA) human medicines committee has recommended Krystal Biotech’s Vyjuvek (beremagene ...
Real-time payments: US respondents place slightly higher importance on speed of payment to participants (87% US sites and 81% ...
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and ...
Around the world, events are being held to mark Rare Disease Day (28 February 2025), with the aim of bringing attention to ...
To deliver treatments for rare diseases more quickly, companies share how they are adapting their launch strategies and ...
A study led by Queen Mary University of London has found 69 previously unidentified genetic determinants of rare diseases.
Just in time for Women’s History Month and International Women’s Day on March 8th, Medscape is proud to showcase its ...
Tired of the disconnect in virtual meetings? Discover how using webcams can enhance communication, build stronger relationships, and create a more engaging work environment.
Eli Lilly has unveiled plans to invest at least $27bn in building four new pharmaceutical manufacturing sites in the US.
Avtozma, which is Celltrion’s twelfth biosimilar to be approved by the EC, is a recombinant humanised monoclonal antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results